747 studies found for:    "Venous Thromboembolism"
Show Display Options
Rank Status Study
21 Withdrawn Systematic Review and Meta-Analysis of Venous Thromboembolism (VTE) Risk Assessment in Hospitalized Medical Patients
Condition: Venous Thromboembolism
Intervention: Other: Application of VTE Risk Assessment
22 Completed Implementing a Tool to Identify Risk for Venous Thromboembolism in Cancer Patients
Conditions: Venous Thromboembolism;   Deep-Vein Thrombosis;   Pulmonary Embolism;   Cancer
Intervention:
23 Recruiting Cancer Patients Diagnosed With Unsuspected Venous Thromboembolism (VTE) on Routine Computed Tomography (CT) Scans
Conditions: Cancer;   Venous Thromboembolism
Intervention: Behavioral: Questionnaires
24 Completed Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Hip Fracture Surgery
Condition: Venous Thromboembolism
Interventions: Drug: DU-176b (edoxaban);   Drug: Enoxaparin  sodium 20mg
25 Not yet recruiting Prophylactic Use of Sodium Enoxaparin for Venous Thromboembolism in High-Risk Abdominal Surgery
Condition: Venous Thromboembolism
Interventions: Drug: Sodium enoxaparin;   Drug: Sodium Enoxaparin clexane
26 Completed A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty
Conditions: Anticoagulants;   Venous Thromboembolism;   Thromboembolism;   Thrombosis;   Enoxaparin Sodium;   Embolism and Thrombosis;   Deep Vein Thrombosis;   DU-176b;   Edoxaban;   Factor Xa;   Oral;   Arthroplasty, Replacement, Hip
Interventions: Drug: DU-176V 15 mg tablets oral, once daily for 2 weeks;   Drug: DU-176b 30 mg tablets, oral once daily for 2 weeks;   Drug: Enoxaparin sodium 20 mg (=2000IU) / 0.2ml twice daily, subcutaneous
27 Completed A Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty
Conditions: Prevention;   Venous Thromboembolism
Interventions: Drug: edoxaban;   Drug: enoxaparin sodium
28 Enrolling by invitation Multicenter Registry for Comparative Effectiveness Analysis of Venous Thromboembolism in Trauma Patients
Conditions: Venous Thromboembolism;   Pulmonary Embolus;   Deep Vein Thrombosis
Intervention:
29 Completed A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty
Conditions: Venous Thromboembolism;   Deep Vein Thrombosis;   Total Knee Arthroplasty;   DU-176b;   Factor Xa
Interventions: Drug: DU-176b;   Drug: Placebo
30 Completed A Study to Assess the Effect of YM150 for Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery
Condition: Venous Thromboembolism
Interventions: Drug: YM150;   Procedure: mechanical prophylaxis
31 Completed Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With Cancer
Condition: Venous Thromboembolism
Intervention:
32 Not yet recruiting Safety of DAbigatran and RIvaroxaban Versus NAdroparin in the Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery
Condition: Venous Thromboembolism
Interventions: Drug: Dabigatran;   Drug: Rivaroxaban;   Drug: Nadroparin
33 Recruiting VTEval Project - A Prospective Cohort Study to Evaluate Diagnosis, Management and Outcome in Individuals With Venous Thromboembolism
Conditions: Venous Thromboembolism (VTE);   Deep Vein Thrombosis (DVT);   Pulmonary Embolism (PE)
Intervention:
34 Completed
Has Results
The Clinical Utility of Thrombelastography in Guiding Prophylaxis of Venous Thromboembolism Following Trauma
Condition: Venous Thromboembolism
Interventions: Drug: Dalteparin sodium;   Drug: Dalteparin sodium/aspirin
35 Completed Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery
Condition: Venous Thromboembolism
Interventions: Drug: Semuloparin sodium;   Drug: Placebo (for Enoxaparin sodium);   Drug: Enoxaparin sodium;   Drug: Placebo (for Semuloparin sodium)
36 Enrolling by invitation Obstructive Sleep Apnea and Venous Thromboembolism
Conditions: Obstructive Sleep Apnea;   Venous Thrombosis;   Pulmonary Embolism;   Venous Thromboembolism
Intervention:
37 Completed Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery
Condition: Venous Thromboembolism
Interventions: Drug: Semuloparin Sodium;   Drug: Enoxaparin sodium;   Drug: Placebo
38 Active, not recruiting A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis
Conditions: Deep Vein Thrombosis;   Coronary Artery Bypass Surgery;   Venous Thromboembolism
Interventions: Drug: Fondaparinux;   Other: Placebo
39 Recruiting Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous Thromboembolism
Conditions: Venous Thromboembolism;   Deep-Vein Thrombosis;   Pulmonary Embolism;   Cancer
Intervention:
40 Terminated Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients With Restricted Mobility
Condition: Venous Thromboembolism
Interventions: Drug: Semuloparin sodium;   Drug: Enoxaparin sodium

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years